Black Belt Therapeutics spins out of Tusk concurrent with acquisition by Roche
Concurrent with Roche’s acquisition of Tusk Therapeutics Ltd., Tusk spun out a new company called Black Belt Therapeutics to continue pursuing oncology candidates in Tusk’s pipeline.
- Large Molecule
- Intra-Biotech Deal
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.